BioChronicles Blog

Engineered Antibodies for Neurodegenerative Disease Research

Neurodegenerative diseases like Alzheimer’s disease (AD) and Parkinson’s disease (PD) are complex and prescient subjects of research, characterized by the accumulation of misfolded proteins in the nervous system that exhibit pathogen behavior (Armstrong, 2020). With as many as 6.2 million Americans with AD and nearly a million with PD in the United States alone, and those numbers expected to rise, the need for comprehensive understanding of the pathways that contribute to neurodegenerative pathogenesis is only growing

Read More »

Chimeric vs. Humanized Antibodies

Antibody engineering and recombinant production have greatly impacted the research, biotechnology, and therapeutics fields. Recombinant DNA technology allows scientists to reformat antibodies into different isotypes, subtypes, species, formats, etc.

Read More »

Quantum Dots

In the first of our three part series on Bioconjugation, we’ll be exploring what’s involved, how it enables life science research, the challenges associated with it, and the excitement in future work.

Read More »

Click Chemistry Crosslinking with dPEG®

In the first of our three part series on Bioconjugation, we’ll be exploring what’s involved, how it enables life science research, the challenges associated with it, and the excitement in future work.

Read More »

Maleimide Crosslinker Selection Guide

In the first of our three part series on Bioconjugation, we’ll be exploring what’s involved, how it enables life science research, the challenges associated with it, and the excitement in future work.

Read More »

It Takes Two to Tango, Part 2: Applications of Bioconjugation

In the previous section, we discussed the methods of bioconjugation. And the marriage of a biomolecule and a small molecule has given rise to various modalities commonly used in biomedical research. Here, we focus on the applications in the fields of therapeutics, diagnostics, protein-protein interactions, and nanotechnology.

Read More »